Amicus Therapeutics (FOLD) News Today $6.22 -0.04 (-0.64%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$6.31 +0.09 (+1.43%) As of 05/23/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FOLD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Purchased by Squarepoint Ops LLCSquarepoint Ops LLC boosted its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 113.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,417,152 shares of the biopharmaceutical company's stock aftMay 25 at 4:34 AM | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Stake Cut by Teza Capital Management LLCTeza Capital Management LLC cut its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 63.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,458 shares of the biopharmaceutical company'sMay 23 at 5:17 AM | marketbeat.comNuveen Asset Management LLC Buys 159,139 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)Nuveen Asset Management LLC lifted its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 4.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,807,420 shares of the biopharmaceutical company's stock afterMay 23 at 4:10 AM | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Recommendation of "Moderate Buy" by AnalystsAmicus Therapeutics, Inc. (NASDAQ:FOLD - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the ten ratings firms that are presently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and seven have issued a buy ratingMay 22 at 1:30 AM | marketbeat.com3,350,000 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Acquired by Vestal Point Capital LPVestal Point Capital LP purchased a new position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,350,0May 21, 2025 | marketbeat.comSovereign s Capital Management LLC Makes New Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Sovereign s Capital Management LLC bought a new position in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 297,830 shares of the biopharmaceutical company's stock, vMay 21, 2025 | marketbeat.comRafferty Asset Management LLC Sells 73,883 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)Rafferty Asset Management LLC lessened its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 18.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 333,391 shares of the biopharmaMay 21, 2025 | marketbeat.comDeutsche Bank AG Grows Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Deutsche Bank AG grew its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 11.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 822,108 shares of the biopharmaceutical company'sMay 20, 2025 | marketbeat.comProsight Management LP Makes New Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Prosight Management LP bought a new stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 920,000 shares of the biopharmaceutical company'sMay 17, 2025 | marketbeat.comJanus Henderson Group PLC Trims Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Janus Henderson Group PLC lowered its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 46.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,395,058 shares of the biopharmaceutical company's stock after selling 2,940,177 sharesMay 17, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Bought by Parkman Healthcare Partners LLCParkman Healthcare Partners LLC increased its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 29.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 784,376 shares of the biopharmaceutical company's stock after puMay 16, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)D. E. Shaw & Co. Inc. lifted its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 132.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,560,410 shares of the biopharmaceutical company's stock after purchasing an additionalMay 16, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by BNP Paribas Financial MarketsBNP Paribas Financial Markets decreased its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 14.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4May 16, 2025 | marketbeat.comOrbimed Advisors LLC Boosts Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Orbimed Advisors LLC increased its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 300.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,285,400 shares of the biopharmaceuMay 15, 2025 | marketbeat.comIs Amicus Therapeutics (FOLD) the Best Low Priced Biotech Stock to Buy Now?May 13, 2025 | insidermonkey.comHudson Bay Capital Management LP Purchases 379,800 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)Hudson Bay Capital Management LP boosted its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 26.7% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,804,800 shares of the biopharmaceutical company's stock after buying aMay 13, 2025 | marketbeat.comNorthern Trust Corp Acquires 187,652 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)Northern Trust Corp grew its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 5.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,371,639 shares of the biopharmaceutical company's stock after acquiring anMay 13, 2025 | marketbeat.comBalyasny Asset Management L.P. Has $8 Million Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Balyasny Asset Management L.P. lessened its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 58.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 849,405 shares of the bioMay 12, 2025 | marketbeat.comBayesian Capital Management LP Acquires 54,100 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)Bayesian Capital Management LP increased its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 422.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 66,900 shares of the biopharmaceuticMay 9, 2025 | marketbeat.comAlgert Global LLC Acquires 165,923 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)Algert Global LLC raised its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 64.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 425,083 shares of the biopharmaceutical company's stockMay 9, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC trimmed its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 32.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 205,702 shares of the biopharmaceutical company's stock aMay 8, 2025 | marketbeat.comAmicus Therapeutics to Present at the Bank of America 2025 Health Care ConferenceMay 7, 2025 | globenewswire.comMarshall Wace LLP Grows Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Marshall Wace LLP boosted its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 254.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 72,968 shares of the biopharmaceutical companMay 4, 2025 | marketbeat.comVoya Investment Management LLC Sells 743,492 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)Voya Investment Management LLC trimmed its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 52.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 676,353 shares of the biopharmaceuticalMay 2, 2025 | marketbeat.comAmicus Therapeutics revenue misses estimates, stock tumblesMay 1, 2025 | in.investing.comPDT Partners LLC Increases Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)PDT Partners LLC lifted its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 39.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 352,498 shares of the biopharmaceutical company's stock after aMay 1, 2025 | marketbeat.comAmicus Therapeutics Inc Reports Q1 2025 Earnings: EPS of -$0. ...May 1, 2025 | gurufocus.comAmicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate UpdatesMay 1, 2025 | globenewswire.comAquatic Capital Management LLC Boosts Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Aquatic Capital Management LLC raised its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 201.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 235,414 shares of the biopharmaceutical company's sMay 1, 2025 | marketbeat.comTower Research Capital LLC TRC Grows Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Tower Research Capital LLC TRC increased its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 419.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 58,075 shaMay 1, 2025 | marketbeat.comDimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United StatesApril 30, 2025 | globenewswire.com38,148 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Bought by Dark Forest Capital Management LPDark Forest Capital Management LP bought a new stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 38,148 shares of the biopharmaceutical company's stock, valued at approximately $359,000. OtherApril 30, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Average Rating of "Moderate Buy" from BrokeragesAmicus Therapeutics, Inc. (NASDAQ:FOLD - Get Free Report) has earned an average rating of "Moderate Buy" from the nine ratings firms that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy ratingApril 27, 2025 | marketbeat.comAmicus Therapeutics (FOLD) to Release Quarterly Earnings on ThursdayAmicus Therapeutics (NASDAQ:FOLD) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-amicus-therapeutics-inc-stock/)April 26, 2025 | marketbeat.comRussell Investments Group Ltd. Has $502,000 Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)Russell Investments Group Ltd. raised its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 539.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 53,282 shares of the biopharmApril 26, 2025 | marketbeat.comTD Cowen Remains a Buy on Amicus (FOLD)April 24, 2025 | markets.businessinsider.comIs Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts?April 23, 2025 | insidermonkey.comIs Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts?April 23, 2025 | msn.com11 Best Guru Stocks to Buy According to Wall Street AnalystsApril 23, 2025 | insidermonkey.comRock Springs Capital Management LP Purchases 1,349,145 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)Rock Springs Capital Management LP raised its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 107.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,599,425 shApril 23, 2025 | marketbeat.comAmicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025April 21, 2025 | globenewswire.comJump Financial LLC Sells 105,944 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)Jump Financial LLC decreased its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 34.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 201,227 shares of the biopharmaceutApril 21, 2025 | marketbeat.comBank of America Securities Reaffirms Their Buy Rating on Amicus (FOLD)April 18, 2025 | markets.businessinsider.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Stock Holdings Lifted by Granite Investment Partners LLCGranite Investment Partners LLC grew its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 11.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,669,534 shares of the biopharmaceuticalApril 15, 2025 | marketbeat.comAmicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Purchased by Renaissance Technologies LLCRenaissance Technologies LLC lifted its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 174.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,108,616 shares of the biopharmaceutical company's stoApril 15, 2025 | marketbeat.comAmicus Therapeutics (NASDAQ:FOLD) Stock Price Down 6.3% - Here's WhyAmicus Therapeutics (NASDAQ:FOLD) Stock Price Down 6.3% - Should You Sell?April 11, 2025 | marketbeat.comIs Amicus Therapeutics, Inc. (FOLD) the Best Low Priced Growth Stock To Invest In?April 11, 2025 | msn.comIs Amicus Therapeutics, Inc. (FOLD) the Best Low Priced Growth Stock To Invest In?April 11, 2025 | insidermonkey.comAnalysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven SoonApril 10, 2025 | uk.finance.yahoo.comIs Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires?April 9, 2025 | finance.yahoo.com Get Amicus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address FOLD Media Mentions By Week FOLD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FOLD News Sentiment▼1.560.75▲Average Medical News Sentiment FOLD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FOLD Articles This Week▼76▲FOLD Articles Average Week Get Amicus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RGEN News HALO News MDGL News IONS News ALKS News BCRX News LGND News CLDX News MNKD News NVAX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FOLD) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amicus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amicus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FOLD Stock Free FOLD Stock Alerts